Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK).

"Disclosure statement : C.L.J.W., A.T., R.Y., Y.B., S.P.C. and G.P. are current employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and may own stock/stock options in Merck & Co., Inc., Rahway, NJ, USA. No other potential conflicts of interest relevant to this article are reported."

"Funding The study was sponsored by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD) and funded by MSD and Janssen Research & Development, LLC (Spring House, PA, USA). Disclosure statement: C.L.J.W., A.T., R.Y., Y.B., S.P.C. and G.P. are current employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and may own stock/stock options in Merck & Co., Inc., Rahway, NJ, USA. No other potential conflicts of interest relevant to this article are reported."